Spencer Pharmaceuticals
- Hilbroy Advisory was retained by Spencer Pharmaceutical to assist in the reverse merger transaction with Emergensys, whereby Jean-Francois Amyot was a director of Emergensys, said information was disclosed to Spencer Pharmaceutical management.
- Hilbroy Advisory owns 500,000 restricted shares of Spencer Pharmaceutical. Hilbroy Advisory, officers, directors, employees and or subsidiary never owned free trading shares of Spencer Pharmaceutical and therefore never traded shares on the open market.
- IAB Media was hired to perform a web based securities awareness campaign and was compensated in RESTRICTED shares, and said compensation was disclosed at the time of campaign.
- Hilbroy Advisory did not introduce Al-Dorra to Spencer Pharmaceutical, this was done by way of a special adviser on middle east and north africa to the Canadian senate.
- Hilbroy Advisory did not come up with a price for the negotiation, but Dr. Arella did and according to management of Spencer, the technology was worth over $1 billion.
- Hilbroy Advisory's services were terminated and Hilbroy Advisory was hired by the representatives of Al-Dorra to oversee the proposed acquisition.
- Hilbroy Advisory hired a law firm to perform the necessary due-diligence and further to the findings, the offer from Al-Dorra changed.
- Hilbroy Advisory was also mandated by the representatives of Al-Dorra to seek a listing on the Frankfurt Stock Exchange.
- Hilbroy Advisory proposed to acquire a dormant shell and reverse the company's stock and change its name. Hilbroy Advisory used the services of Ven Bank as well as Schnigge since they are the same listing agent that undertook the Hilbroy listing.
- Jean-Francois Amyot has a power of attorney to setup the corporation on behalf of the middle east representatives and Hail First Pharma is to be relisted on the Frankfurt Stock Exchange pursuant to a filing of an information statement.
- Hail First Pharma is currently still a dormant shell with assets but no operations.
- Hail First Pharma may be abandoned if no transaction can be agreed upon with Spencer Pharmaceutical
